Technical Analysis for RLYB - Rallybio Corporaton

Grade Last Price % Change Price Change
F 8.33 0.00% 0.00
RLYB closed down 6.09 percent on Tuesday, January 18, 2022, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical RLYB trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -6.09%
NR7 Range Contraction -6.09%
Wide Bands Range Expansion -6.09%
Older End-of-Day Signals for RLYB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 1 minute ago
Rose Above Previous Day's High about 1 hour ago
Up 3% about 1 hour ago
Up 2% about 1 hour ago
Up 1% about 1 hour ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Rare Diseases Metabolic Disorders Severe And Rare Diseases

Is RLYB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 25.78
52 Week Low 8.06
Average Volume 49,142
200-Day Moving Average 0.00
50-Day Moving Average 11.96
20-Day Moving Average 9.82
10-Day Moving Average 9.39
Average True Range 1.25
ADX 19.96
+DI 16.81
-DI 25.37
Chandelier Exit (Long, 3 ATRs) 7.98
Chandelier Exit (Short, 3 ATRs) 11.80
Upper Bollinger Bands 11.51
Lower Bollinger Band 8.12
Percent B (%b) 0.06
BandWidth 34.47
MACD Line -0.76
MACD Signal Line -0.79
MACD Histogram 0.0282
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.98
Resistance 3 (R3) 9.01 8.83 8.87
Resistance 2 (R2) 8.83 8.67 8.81 8.83
Resistance 1 (R1) 8.58 8.56 8.49 8.55 8.80
Pivot Point 8.40 8.40 8.36 8.38 8.40
Support 1 (S1) 8.15 8.24 8.06 8.12 7.86
Support 2 (S2) 7.97 8.13 7.95 7.83
Support 3 (S3) 7.72 7.97 7.79
Support 4 (S4) 7.69